Kantonsspital Liestal
About Kantonsspital Liestal
"Kantonsspital Baselland Liestal..."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Swiss Group for Clinical Cancer Research
30
Prof. Dr. Jörg Leuppi
4
Fondazione Epatocentro Ticino
3
Kantonsspital Liestal
2
Terumo Europe N.V.
2
AO Clinical Investigation and Publishing Documentation
1
Advanz Pharma
1
Andrej Trampuz
1
Arteriogenesis Competence Network
1
Biotronik AG
1
Celgene
1
Clinical Trials at Kantonsspital Liestal
During the past decade, Kantonsspital Liestal conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 1 clinical trials were completed, i.e. on
average, 3.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients
2001-04-04
2037-12-01
Active, not recruiting
232
The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)
2005-05-01
2008-06-01
Completed
250
Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
2003-11-01
2004-10-01
Completed
63
Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma
2004-06-08
2017-12-19
Completed
270
Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
2004-06-01
2006-02-01
Completed
74
Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer
2005-05-01
2011-04-01
Completed
13
Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
2004-03-01
2010-08-01
Completed
21
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
2007-03-01
2008-07-01
Completed
735
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kantonsspital Liestal" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 30 trials, followed by "Prof. Dr. Jörg Leuppi" with 4 trials
sponsored, "Fondazione Epatocentro Ticino" with 3 trials sponsored, "Kantonsspital Liestal" with 2 trials sponsored and "Terumo Europe N.V."
with 2 trials sponsored. Other sponsors include 15 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kantonsspital Liestal"
#1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Kantonsspital Liestal" with 2 trials as a collaborator, "University of Lausanne Hospitals" with 2 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator and "Anticancer Fund, Belgium" with 1 trials as a collaborator. Other collaborators include 41 different institutions and companies that were
collaborators in the rest 51 trials.
Clinical Trials Conditions at Kantonsspital Liestal
According to Clinical.Site data, the most researched conditions in "Kantonsspital Liestal" are
"Lung Cancer" (4 trials), "Lymphoma" (4 trials), "Breast Cancer" (3 trials), "Esophageal Cancer" (3 trials) and "Prostate Cancer" (3 trials). Many other conditions were trialed in "Kantonsspital Liestal" in a lesser frequency.
Clinical Trials Intervention Types at Kantonsspital Liestal
Most popular intervention types in "Kantonsspital Liestal" are "Drug" (37 trials), "Biological" (9 trials), "Other" (9 trials), "Procedure" (8 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Ibrutinib" (4 trials), "Radiotherapy" (3 trials), "cetuximab" (3 trials) and "cisplatin" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Kantonsspital Liestal
The vast majority of trials in "Kantonsspital Liestal" are
50 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Kantonsspital Liestal
Currently, there are NaN active trials in "Kantonsspital Liestal".
undefined are not yet recruiting,
12 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 28 completed trials in Kantonsspital Liestal,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Kantonsspital Liestal, 2 "Phase 1"
clinical trials were conducted, 23 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 6 trials that are defined as “Not Applicable".
Departments of Kantonsspital Liestal
Kantonsspital Liestal has several departments that took part in Clinical trials: "Kantonsspital Baselland (Bruderholz, Liestal, Laufen), Department of Orthopaedic Surgery and Traumatology" - 2 trials
Departments List